(Q37133892)

18 August 2017

1 reference

title

Skeletal involvement in adult patients with endogenous hypercortisolism (English)

1 reference

18 August 2017

Chiodini I

1

1 reference

18 August 2017

Torlontano M

2

1 reference

18 August 2017

Carnevale V

3

1 reference

18 August 2017

Trischitta V

4

1 reference

18 August 2017

Scillitani A

5

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Journal of Endocrinological Investigation

18 August 2017

published in

1 reference

18 August 2017

volume

31

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

267-276

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345601

18 August 2017

exact match

0 references

cites work

Perspectives on glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Cushing's syndrome and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Mechanisms of glucocorticoid action in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Notch 1 impairs osteoblastic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Histomorphometric analysis of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Corticosteroids and fractures: a close encounter of the third cell kind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Malabsorption of calcium in corticosteroid-induced osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Hypercorticism blunts circadian variations of osteocalcin regardless of nutritional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Osteoporosis associated with excess glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Quantitative computed tomography at the axial and peripheral skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Advanced imaging assessment of bone quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Quantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: reference data for various measurement sites, limitations and application possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Increased risk of osteoporotic fractures in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Suppressed levels of serum cortisol following high-dose oral dexamethasone administration differ between healthy postmenopausal females and patients with established primary vertebral osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345601

Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?

21 January 2018

1 reference

12 December 2020

Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism.

1 reference

12 December 2020

Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.

1 reference

12 December 2020

Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome

1 reference

12 December 2020

Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features

1 reference

12 December 2020

Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome

1 reference

12 December 2020

Bone loss rate in adrenal incidentalomas: a longitudinal study.

1 reference

12 December 2020

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

12 December 2020

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.

1 reference

12 December 2020

Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.

1 reference

12 December 2020

Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome

1 reference

12 December 2020

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Osteocalcin levels in Cushing's disease before and after treatment

1 reference

12 December 2020

Normal bone mineral density following cure of Cushing's syndrome

1 reference

12 December 2020

Molecular basis and clinical application of biological markers of bone turnover

1 reference

12 December 2020

Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome

1 reference

12 December 2020

Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism

1 reference

12 December 2020

Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome

1 reference

12 December 2020

The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis

1 reference

12 December 2020

Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma

1 reference

12 December 2020

Osteoporotic fractures at presentation of Cushing's disease: two case reports and a literature review

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345601

1 reference

18 August 2017

1 reference